Unknown

Dataset Information

0

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.


ABSTRACT: Diabetic retinopathy (DR) is a chronic complication of diabetes and a leading cause of blindness in the industrialized world. Traditional risk factors, such as glycemic control and duration of diabetes, are unable to explain why some individuals remain protected while others progress to a more severe form of the disease. Differences are also observed in DR heritability as well as the response to anti-vascular endothelial growth factor (VEGF) treatment. This review discusses various aspects of genetics in DR to shed light on DR pathogenesis and treatment. First, we discuss the global burden of DR followed by a discussion on disease pathogenesis as well as the role genetics plays in the prevalence and progression of DR. Subsequently, we provide a review of studies related to DR's genetic contribution, such as candidate gene studies, linkage studies, and genome-wide association studies (GWAS) as well as other clinical and meta-analysis studies that have identified putative candidate genes. With the advent of newer cutting-edge technologies, identifying the genetic components in DR has played an important role in understanding DR incidence, progression, and response to treatment, thereby developing newer therapeutic targets and therapies.

SUBMITTER: Bhatwadekar AD 

PROVIDER: S-EPMC8394456 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Bhatwadekar Ashay D AD   Shughoury Aumer A   Belamkar Ameya A   Ciulla Thomas A TA  

Genes 20210731 8


Diabetic retinopathy (DR) is a chronic complication of diabetes and a leading cause of blindness in the industrialized world. Traditional risk factors, such as glycemic control and duration of diabetes, are unable to explain why some individuals remain protected while others progress to a more severe form of the disease. Differences are also observed in DR heritability as well as the response to anti-vascular endothelial growth factor (VEGF) treatment. This review discusses various aspects of ge  ...[more]

Similar Datasets

| S-EPMC4125976 | biostudies-other
| S-EPMC10292832 | biostudies-literature
| S-EPMC4664538 | biostudies-literature
| S-EPMC2913807 | biostudies-literature
| S-EPMC3947937 | biostudies-literature
| S-EPMC3763680 | biostudies-literature
| PRJNA747548 | ENA
| PRJNA747549 | ENA
| S-EPMC4821125 | biostudies-literature
| S-EPMC6461978 | biostudies-literature